Literature DB >> 15007111

Intensive statin therapy--a sea change in cardiovascular prevention.

Eric J Topol.   

Abstract

Mesh：

Substances：

Year:  2004        PMID： 15007111     DOI： 10.1056/NEJMe048061

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  23 in total

1.  New benefits of statin treatment.

Authors:  Guenther Boden
Journal:  Curr Diab Rep       Date:  2005-06       Impact factor: 4.810

Review 2.  Statins and CVD prevention in the diabetic population: implications of the CARDS trial.

Authors:  Omar Murad; John Palmer; James Sowers; Samy I McFarlane
Journal:  Curr Diab Rep       Date:  2005-06       Impact factor: 4.810

3.  Brain cholesterol turnover required for geranylgeraniol production and learning in mice.

Authors:  Tiina J Kotti; Denise M O Ramirez; Brad E Pfeiffer; Kimberly M Huber; David W Russell
Journal:  Proc Natl Acad Sci U S A       Date:  2006-02-27       Impact factor: 11.205

4.  'Me-Too' Innovation in Pharmaceutical Markets.

Authors:  Anupam B Jena; John E Calfee; Edward C Mansley; Tomas J Philipson
Journal:  Forum Health Econ Policy       Date:  2009-11-04

5.  Dose-dependency in pleiotropic effects of atorvastatin.

Authors:  Masatoshi Fujita; Tatsuya Morimoto; Masaki Ikemoto; Mayu Takeda; Akiko Ikai; Kunihisa Miwa
Journal:  Int J Angiol       Date:  2007

6.  Simvastatin promotes Th2-type responses through the induction of the chitinase family member Ym1 in dendritic cells.

Authors:  Meenakshi Arora; Li Chen; Melissa Paglia; Iain Gallagher; Judith E Allen; Yatin M Vyas; Anuradha Ray; Prabir Ray
Journal:  Proc Natl Acad Sci U S A       Date:  2006-05-08       Impact factor: 11.205

7.  Drug costs associated with non-adherence to cholesterol management guidelines for primary prevention of cardiovascular disease in an elderly population: the Rotterdam study.

Authors:  Pearl D Gumbs; W M Monique Verschuren; Aukje K Mantel-Teeuwisse; Ardine G de Wit; Albert Hofman; Paul H Trienekens; Bruno H Ch Stricker; Antonius de Boer; Olaf H Klungel
Journal:  Drugs Aging       Date:  2006       Impact factor: 3.923

8.  Low-density lipoprotein cholesterol lowering in the prevention of CHD: how low should we go?

Authors:  William L Isley
Journal:  Curr Treat Options Cardiovasc Med       Date:  2006-08

Review 9.  Isoprenoids: remarkable diversity of form and function.

Authors:  Sarah A Holstein; Raymond J Hohl
Journal:  Lipids       Date:  2004-04       Impact factor: 1.880

10.  Statins inhibit the growth of variant human embryonic stem cells and cancer cells in vitro but not normal human embryonic stem cells.

Authors:  K Gauthaman; N Manasi; A Bongso
Journal:  Br J Pharmacol       Date:  2009-05-11       Impact factor: 8.739
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.